This study demonstrated that lycopene, administered in combination with a reduced insulin dose, effectively controlled the glycemia of type 1 diabetic rats without causing hypoglycemia, decreasing glycoxidative stress, and in parallel decreased dyslipidemia and increased the PON-1 activity, which may be interesting to improve cardiovascular diseases. This evidence concerns the gene PON1 and Hypoglycemia.